XML 53 R39.htm IDEA: XBRL DOCUMENT
v3.24.1

STOCK-BASED COMPENSATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
SUMMARY OF STOCK OPTIONS | A summary of stock option awards as of December 31, 2023 and changes during the two-year period ended December 31, 2023 is presented below: SUMMARY OF STOCK OPTIONS
Stock Options |  | Number Outstanding |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Outstanding at January 1, 2022 |  |  | 441,425 |  |  | $ | 38.50 |  |  |  |  |  |  |  |  |
Options granted |  |  | 716,156 |  |  | $ | 2.72 |  |  |  |  |  |  |  |  |
Options canceled or expired |  |  | (397,361 | ) |  | $ | 39.06 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 760,220 |  |  | $ | 4.55 |  |  |  |  |  |  |  |  |
Options granted |  |  | 432,500 |  |  | $ | 1.23 |  |  |  |  |  |  |  |  |
Options canceled or expired |  |  | (129,238 | ) |  | $ | 9.37 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 1,063,482 |  |  | $ | 2.61 |  |  |  | 8.8 |  |  | $ | – |
Exercisable at December 31, 2023 |  |  | 453,766 |  |  | $ | 3.64 |  |  |  | 8.5 |  |  | $ | – |
SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS | A summary of the status of the Company’s non-vested restricted stock awards as of December 31, 2023 and changes during the two-year period ended December 31, 2023, is presented below: SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS
Restricted Stock |  | Number Outstanding |  |  | Weighted Average Grant Date Fair Value |
Non-vested stock awards outstanding at January 1, 2022 |  |  | 1,481 |  |  | $ | 12.36 |
Granted |  |  | 69,650 |  |  | $ | 1.92 |
Vested and issued |  |  | (1,381 | ) |  | $ | 12.04 |
Forfeited |  |  | (100 | ) |  | $ | 9.45 |
Non-vested stock awards outstanding at December 31, 2022 |  |  | 69,650 |  |  | $ | 1.92 |
Granted |  |  | 22,100 |  |  | $ | 0.92 |
Vested and issued |  |  | (59,450 | ) |  | $ | 1.91 |
Forfeited |  |  | (200 | ) |  | $ | 4.60 |
Non-vested stock awards outstanding at December 31, 2023 |  |  | 32,100 |  |  | $ | 1.23 |
SUMMARY OF STOCK OPTIONS OUTSTANDING | A summary of stock options outstanding at December 31, 2023 by price range is as follows: SUMMARY OF STOCK OPTIONS OUTSTANDING
|  |  |  |  | Options Outstanding |  |  | Options Exercisable |
Range of Exercise Prices |  | Number |  |  | Weighted Average Remaining Contractual Term (in years) |  |  | Weighted Average Exercise Price |  |  | Number |  |  | Weighted Average Remaining Contractual Term (in years) |  |  | Weighted Average Exercise Price |
Up to $1.95 |  |  | 689,113 |  |  |  | 9.1 |  |  | $ | 1.74 |  |  |  | 315,867 |  |  |  | 8.8 |  |  | $ | 1.71 |
$1.96 to $10.00 |  |  | 347,975 |  |  |  | 8.4 |  |  | $ | 3.27 |  |  |  | 113,936 |  |  |  | 8.2 |  |  | $ | 4.63 |
Above $10.01 |  |  | 26,394 |  |  |  | 6.3 |  |  | $ | 23.69 |  |  |  | 23,963 |  |  |  | 6.1 |  |  | $ | 24.29 |
|  |  | 1,063,482 |  |  |  |  |  |  |  |  |  |  |  | 453,766 |  |  |  |  |  |  |  |  |
SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED | The fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Imunon’s stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate. The Company used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model: SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Risk-free interest rate |  |  | 3.39% to 4.81 | % |  |  | 1.74 % to 3.97 | %
Expected volatility |  |  | 100.0% to 113.6 | % |  |  | 100.0% to 113.9 | %
Expected life (in years) |  |  | 7.5 to 10.0 |  |  |  | 7.5 to 10.0 |
Expected dividend yield |  |  | 0.0 | % |  |  | 0.0 | %

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration